ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0192

Associations Between Social Determinants of Health and Acute Care Use Among Individuals with Lupus, Rheumatoid Arthritis and Osteoarthritis in the All of Us Research Program

Candace Feldman1, Leah Santacroce1, Yomaira Silva2, Jing Cui1, Jeong Yee1, Elizabeth Karlson1 and Karen Costenbader3, 1Brigham and Women's Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA, 3Brigham and Women's Hospital/ Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2024

Keywords: Access to care, Disparities, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Healthcare Disparities in Rheumatology Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Adverse social determinants of health (SDoH), or social risk factors like economic insecurities, inadequate health care access and neighborhood vulnerability, contribute to modifiable inequities in rheumatic disease care and outcomes. We examined associations between these factors and rates of acute care use (hospitalizations and emergency department visits) in a national cohort of individuals with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and osteoarthritis (OA).

Methods: We included adults (≥18 years) enrolled in the All of Us Research Program with ≥2 ICD-10 codes for SLE, RA or OA ≥2 years prior to enrollment, and SDoH survey responses at enrollment. We developed indices for economic insecurities, health care access challenges, and neighborhood vulnerabilities comprised of counts of social needs reported on the SDoH surveys within each domain. We examined discrimination as an independent social risk factor using the Everyday Discrimination Scale. We determined exposure categories based on data distribution. We measured episodes of acute care use (counts of ED visits and hospitalizations) following All of Us enrollment. We used multivariable negative binomial regression models to examine associations between presence and degree of social risk factor exposure and episodes of acute care use, adjusting for demographic factors, rheumatic condition, and comorbidities.

Results: We identified 9,390 individuals; 412 with SLE, 1,218 with RA and 8,468 with OA, and with demographic differences across cohorts (Table 1). The mean (IQR) follow-up time was 4.2 (2.7, 5.3) years, and the mean (IQR) number of acute care events was 3.4 (0, 2). Overall, 40.5% of individuals experienced ≥1 economic insecurity, 59% ≥1 health care access challenge, and 58% ≥1 neighborhood vulnerability, with the greatest burden reported among individuals with SLE (Figure 1). We observed dose-dependent associations between social risk factors and acute care use; greater burden of social risk factors was associated with higher rates of use (Table 2). Repeated experiences of discrimination were associated with significantly higher rates of acute care use, compared to no or less frequent experiences (IRR 1.34, 95% CI 1.20-1.51). The strongest association was seen with ≥3 health care access challenges compared to no challenges (IRR 1.75, 95% CI 1.51-2.02).

Conclusion: In this national cohort of individuals with SLE, RA and OA, we observed a significant burden of social risk factors that were strongly associated with rates of acute care use. Further studies are needed to design and test multilevel interventions to determine whether addressing these needs reduces the profound inequities in rheumatic disease care and outcomes.

Supporting image 1

All if Us Cohort Characteristics Overall and by Disease

Supporting image 2

Figure 1. Distribution of Social Risk Factors by Rheumatic Condition

Supporting image 3

Table 2. Multivariable Negative Binomial Models Demonstrating Associations Between Burden of Social Risk Factors and Acute Care Use (N=9,390)


Disclosures: C. Feldman: Bain Capital, LP, 2, BMS Foundation, 5, Curio Bioscience, 12, My husband is a founder and will (but has not to date) receive equity., Harvard Pilgrim, 2, OM1, Inc., 2; L. Santacroce: None; Y. Silva: None; J. Cui: None; J. Yee: None; E. Karlson: None; K. Costenbader: Amgen, 2, 5, AstraZeneca, 5, Bain HealthSciences, 2, Bristol-Myers Squibb(BMS), 2, Cabaletta Bio, 2, 5, Exagen, 5, Gilead, 5, Glaxo Smith Kline, 2, 5, Merck, 5.

To cite this abstract in AMA style:

Feldman C, Santacroce L, Silva Y, Cui J, Yee J, Karlson E, Costenbader K. Associations Between Social Determinants of Health and Acute Care Use Among Individuals with Lupus, Rheumatoid Arthritis and Osteoarthritis in the All of Us Research Program [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/associations-between-social-determinants-of-health-and-acute-care-use-among-individuals-with-lupus-rheumatoid-arthritis-and-osteoarthritis-in-the-all-of-us-research-program/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-between-social-determinants-of-health-and-acute-care-use-among-individuals-with-lupus-rheumatoid-arthritis-and-osteoarthritis-in-the-all-of-us-research-program/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology